Washington, DC 20006-5349
HELPLINE
In the first of a special two-part series of Meet the Mesothelioma Experts, we interview our 2015 mesothelioma research grant recipients. In this session, we…
We are pleased to announce the funding of five new mesothelioma research projects by the Meso Foundation. To date the Meso Foundation has funded 99…
We have recently announced the 2016 dates for our International Symposium on Malignant Mesothelioma. In an effort to make it easier for the mesothelioma-affected community…
Mary Hesdorffer, APRN, the executive director of the Mesothelioma Applied Research Foundation, was one of the 30 international speakers at the 2015 Weinman Symposium at…
The Meso Foundation is pleased to announce that Tobias Peikert, MD, of Mayo Clinic, has taken on the role of its Science Advisory Board’s chair. The…
On October 14, the SELLAS Life Sciences Group, a biotech company leading a Phase 2 study of the WT1 vaccine, released the study’s promising data. The…
Last week, at the World Conference on Lung Cancer, Dr. Raffit Hassan presented promising data on a novel agent, anetumab ravtansine, also known as BAY…
The Meso Foundation congratulates Dr. Harvey Pass for receiving the Merit Award from the International Association for the Study of Lung Cancer (IASLC). Dr. Pass…
If you attended our International Symposium on Malignant Mesothelioma in March of this year, you may recall the buzz of excitement that coursed throughout the…
Over the last several year or so, a number of people have posted information about various supplements they favor, both for general health and, occasionally,…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
